183 related articles for article (PubMed ID: 23798669)
1. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
Descamps D; Assoumou L; Chaix ML; Chaillon A; Pakianather S; de Rougemont A; Storto A; Dos Santos G; Krivine A; Delaugerre C; Montes B; Izopet J; Charpentier C; Wirden M; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Guinard J; Tamalet C; Cottalorda J; Marcelin AG; Desbois D; Henquell C; Calvez V; Brun-Vézinet F; Masquelier B; Costagliola D;
J Antimicrob Chemother; 2013 Nov; 68(11):2626-31. PubMed ID: 23798669
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
Frange P; Assoumou L; Descamps D; Chéret A; Goujard C; Tran L; Gousset M; Avettand-Fenoël V; Bocket L; Fafi-Kremer S; Guinard J; Morand-Joubert L; Nicot F; Plantier JC; Rogez S; Wirden M; Rouzioux C; Meyer L; Chaix ML; ;
J Antimicrob Chemother; 2015 Jul; 70(7):2084-9. PubMed ID: 25885327
[TBL] [Abstract][Full Text] [Related]
3. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
[TBL] [Abstract][Full Text] [Related]
4. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
Assoumou L; Bocket L; Pallier C; Grude M; Ait-Namane R; Izopet J; Raymond S; Charpentier C; Visseaux B; Wirden M; Trabaud MA; Le Guillou-Guillemette H; Allaoui C; Henquell C; Krivine A; Dos Santos G; Delamare C; Bouvier-Alias M; Montes B; Ferre V; De Monte A; Signori-Schmuck A; Maillard A; Morand-Joubert L; Tumiotto C; Fafi-Kremer S; Amiel C; Barin F; Marque-Juillet S; Courdavault L; Vallet S; Beby-Defaux A; de Rougemont A; Fenaux H; Avettand-Fenoel V; Allardet-Servent A; Plantier JC; Peytavin G; Calvez V; Chaix ML; Descamps D;
J Antimicrob Chemother; 2019 May; 74(5):1417-1424. PubMed ID: 30753724
[TBL] [Abstract][Full Text] [Related]
5. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
7. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
[TBL] [Abstract][Full Text] [Related]
8. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
[TBL] [Abstract][Full Text] [Related]
10. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.
Oette M; Reuter S; Kaiser R; Lengauer T; Fätkenheuer G; Knechten H; Hower M; Pfister H; Häussinger D;
Intervirology; 2012; 55(2):154-9. PubMed ID: 22286886
[TBL] [Abstract][Full Text] [Related]
14. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
Yerly S; von Wyl V; Ledergerber B; Böni J; Schüpbach J; Bürgisser P; Klimkait T; Rickenbach M; Kaiser L; Günthard HF; Perrin L;
AIDS; 2007 Oct; 21(16):2223-9. PubMed ID: 18090050
[TBL] [Abstract][Full Text] [Related]
15. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):73-8. PubMed ID: 12003179
[TBL] [Abstract][Full Text] [Related]
16. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.
Chaix ML; Descamps D; Wirden M; Bocket L; Delaugerre C; Tamalet C; Schneider V; Izopet J; Masquelier B; Rouzioux C; Meyer L; Costagliola D; ; ;
AIDS; 2009 Mar; 23(6):717-24. PubMed ID: 19279445
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Nieto AI; Paz-Bailey G
J Med Virol; 2012 Oct; 84(10):1514-21. PubMed ID: 22930496
[TBL] [Abstract][Full Text] [Related]
18. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
Lambert-Niclot S; Charpentier C; Storto A; Fofana DB; Soulié C; Fourati S; Visseaux B; Wirden M; Morand-Joubert L; Masquelier B; Flandre P; Calvez V; Descamps D; Marcelin AG
J Antimicrob Chemother; 2013 Jun; 68(6):1237-42. PubMed ID: 23361642
[TBL] [Abstract][Full Text] [Related]
20. Infrequent transmission of HIV-1 drug-resistant variants.
Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
